KDA Group Launches Strategic Advisory Board

About this update from Kda Group Inc.

[{"type":"text","content":"KDA Group Launches Strategic Advisory Board(via TheNewswire)\n \n \n\n\n \n \nThetford Mines, Quebec - TheNewswire - May 7, 2020 - KDA Group Inc. (TSXV:KDA) (\"KDA\" or the \"Corporation\") is pleased to announce the formation of its strategic advisory board (the \"Strategic Board\"), comprised of respected business leaders who will provide guidance and assistance to KDA's management team in its efforts and decision-making to build, strengthen and grow its business model.\n\n\n \n\"We are proud to have been able to bring together such a remarkable group of individuals with exceptional track records as leaders in their respective industries. The Strategic Board will play a specific role in providing guidance and insight to the Corporation's management as part of our national and global growth strategy. We look forward working together from now on,\" said Marc Lemieux, Chief Executive Officer of KDA.\n\n\n \nInaugural members of KDA's Strategic Board are as follows:\n\n\n \nSylvain Duvernay - Mr. Duvernay holds a Bachelor's degree in Business Administration and a Certificate in International Trade. He has over 20 years of experience in pharmaceutical and international business.\n\n\n \nMr. Duvernay filled the position of Vice-President for Strides Arcolab Ltd a pharmaceutical generic product company involved in softgel, injectable and solid dose manufacturing. He led its Canadian operations as well as its business development in the United States.\n\n\n \nIn 2008, Sylvain was behind the acquisition of the Bristol-Myers Squibb facility in Candiac where he developed a business model for the injectable business and acted as the President and CEO for the new entity, Uman Pharma Inc.\n\n\n \nThe company was sold to Pharmascience in November 2014 (now Pharmascience Global lnjectables). He stayed two years for the integration before moving to Capcium, a softgel manufacturing company for the pharmaceutical and nutraceutical sectors.\n\n\n \nAs Capcium's CEO, he leads the strategy and the construction of a state of the art facility that will meet FDA, EMA and Health Canada standard.\n\n\n \nJean-Pierre Robert - Mr. Robert is very much involved in the post-COVID-19 preparations for the pharmaceutical and medical equipment sectors.\n\n\n \nMr. Robert has held several positions including Executive Vice President of Tyco Healthcare/Mallinckrod...

More updates from Kda Group Inc.